Jump to Content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report
Download Free Sample View Pricing
Home  ›  Healthcare & Medical Devices  ›  Oncolytic Virus Immunotherapy Market

Oncolytic Virus Immunotherapy Market Size & Growth Forecast 2027–2036, By Segments (Route of Administration, End-user, Application, Virus Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 2811| Published Date: Sep-2026| Format: PDF, Excel
Report Description Table of Contents (ToC) Request Free Sample Report →
Table of Contents (ToC)

Chapter 1. Methodology and Scope

  • Methodology Segmentation & Scope
  • Market Definitions
  • Research Methodology
  • Research Scope and Assumptions

Chapter 2. Executive Summary

  • Market Outlook
  • Segment Outlook
  • Competitive Insights

Chapter 3. Oncolytic Virus Immunotherapy Industry Insights

  • Market Introduction
  • Industry Value Chain Analysis
  • Market Dynamics
    • Market Drivers Analysis
    • Market Restraints Analysis
    • Industry Opportunities
  • Regulatory Framework
  • Analysis Tools
    • Porter’s Analysis
      • Bargaining Power of the Suppliers
      • Bargaining Power of the Buyers
      • Threats of sSbstitution
      • Threats From New Entrants
    • PESTEL Analysis
      • Political Landscape
      • Economic and Social Landscape
      • Technological Landscape
      • Environmental Landscape
      • Legal Landscape

Chapter 4. Oncolytic Virus Immunotherapy Market Estimates 2022–2036 (USD Billion) & Trend Analysis, by Route of Administration

  • Intratumoral Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Intravenous Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2036 (USD Billion)

Chapter 5. Oncolytic Virus Immunotherapy Market Estimates 2022–2036 (USD Billion) & Trend Analysis, by End-user

  • Hospitals & Clinics Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Cancer Research Institutes Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Ambulatory Surgical Centers Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2036 (USD Billion)

Chapter 6. Oncolytic Virus Immunotherapy Market Estimates 2022–2036 (USD Billion) & Trend Analysis, by Application

  • Melanoma Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Breast Cancer Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Lung Cancer Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Ovarian Cancer Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Prostate Cancer Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2036 (USD Billion)

Chapter 7. Oncolytic Virus Immunotherapy Market Estimates 2022–2036 (USD Billion) & Trend Analysis, by Virus Type

  • Herpes Simplex Virus (HSV) Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Adenovirus Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Vaccinia Virus Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Newcastle Disease Virus Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Reovirus Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2036 (USD Billion)

Chapter 8. Oncolytic Virus Immunotherapy Market Estimates 2022–2036 (USD Billion) & Trend Analysis, by Region & Countries

  • Oncolytic Virus Immunotherapy Share, By Region
  • North America
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • U.S.
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Canada
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
  • Europe
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • UK
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Germany
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • France
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Italy
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Spain
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Russia
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
  • Asia Pacific
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • China
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • India
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Japan
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Australia
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • South Korea
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
  • Latin America
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Mexico
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Brazil
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Argentina
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
  • Middle East & Africa
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • Saudi Arabia
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • UAE
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)
    • South Africa
      • Market Estimates and Forecasts, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by End-user, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Application, 2022–2036 (USD Billion)
      • Market Estimates and Forecast by Virus Type, 2022–2036 (USD Billion)

Chapter 9. Competitive Landscape

  • Company Overview
  • Company Market Share Analysis
  • Company Heat Map Analysis
  • Company SWOT Analysis
  • Company Financial Performance
  • Strategy Mapping
    • Expansion
    • Mergers & Acquisition
    • Partnerships & Collaborations
    • New Product Launches
    • Research and Development
  • Company Profiles
    • Amgen Inc. (United States)
    • Replimune Group Inc. (United States)
    • Genelux Corporation (United States)
    • Oncorus Inc. (United States)
    • TILT Biotherapeutics Ltd (Finland)
    • Sorrento Therapeutics Inc. (United States)
    • Daiichi Sankyo Company Limited (Japan)
    • AstraZeneca plc (United Kingdom)
    • Bristol Myers Squibb Company (United States)
    • Roche Holding AG (Switzerland)

List of Tables

  • Global Oncolytic Virus Immunotherapy Market, 2022–2036 (USD Billion)
  • Global Oncolytic Virus Immunotherapy Market, by Region, 2022–2036 (USD Billion)
  • Global Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Global Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Global Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Global Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Intratumoral Segment by Region, 2022–2036 (USD Billion)
  • Intravenous Segment by Region, 2022–2036 (USD Billion)
  • Others Segment by Region, 2022–2036 (USD Billion)
  • Hospitals & Clinics Segment by Region, 2022–2036 (USD Billion)
  • Cancer Research Institutes Segment by Region, 2022–2036 (USD Billion)
  • Ambulatory Surgical Centers Segment by Region, 2022–2036 (USD Billion)
  • Others Segment by Region, 2022–2036 (USD Billion)
  • Melanoma Segment by Region, 2022–2036 (USD Billion)
  • Breast Cancer Segment by Region, 2022–2036 (USD Billion)
  • Lung Cancer Segment by Region, 2022–2036 (USD Billion)
  • Ovarian Cancer Segment by Region, 2022–2036 (USD Billion)
  • Prostate Cancer Segment by Region, 2022–2036 (USD Billion)
  • Others Segment by Region, 2022–2036 (USD Billion)
  • Herpes Simplex Virus (HSV) Segment by Region, 2022–2036 (USD Billion)
  • Adenovirus Segment by Region, 2022–2036 (USD Billion)
  • Vaccinia Virus Segment by Region, 2022–2036 (USD Billion)
  • Newcastle Disease Virus Segment by Region, 2022–2036 (USD Billion)
  • Reovirus Segment by Region, 2022–2036 (USD Billion)
  • Others Segment by Region, 2022–2036 (USD Billion)
  • North America Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • North America Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • North America Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • North America Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • U.S. Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • U.S. Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • U.S. Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • U.S. Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Canada Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Canada Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Canada Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Canada Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Europe Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Europe Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Europe Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Europe Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • UK Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • UK Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • UK Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • UK Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Germany Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Germany Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Germany Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Germany Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • France Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • France Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • France Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • France Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Italy Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Italy Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Italy Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Italy Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Spain Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Spain Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Spain Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Spain Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Russia Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Russia Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Russia Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Russia Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Asia Pacific Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Asia Pacific Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Asia Pacific Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Asia Pacific Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • China Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • China Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • China Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • China Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • India Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • India Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • India Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • India Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Japan Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Japan Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Japan Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Japan Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Australia Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Australia Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Australia Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Australia Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • South Korea Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • South Korea Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • South Korea Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • South Korea Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Latin America Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Latin America Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Latin America Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Latin America Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Mexico Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Mexico Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Mexico Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Mexico Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Brazil Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Brazil Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Brazil Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Brazil Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Argentina Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Argentina Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Argentina Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Argentina Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Middle East & Africa Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Middle East & Africa Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Middle East & Africa Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Middle East & Africa Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • UAE Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • UAE Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • UAE Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • UAE Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • Saudi Arabia Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • Saudi Arabia Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • Saudi Arabia Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • Saudi Arabia Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)
  • South Africa Oncolytic Virus Immunotherapy Market, by Route of Administration, 2022–2036 (USD Billion)
  • South Africa Oncolytic Virus Immunotherapy Market, by End-user, 2022–2036 (USD Billion)
  • South Africa Oncolytic Virus Immunotherapy Market, by Application, 2022–2036 (USD Billion)
  • South Africa Oncolytic Virus Immunotherapy Market, by Virus Type, 2022–2036 (USD Billion)

List of Figures

  • Market Snapshot
  • Segment Snapshot
  • Competitive Landscape Snapshot
  • Industry Value Chain Analysis
  • Market Dynamics
  • PORTER’s Analysis
  • PESTEL Analysis
  • Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion), by Route of Administration
  • Intratumoral Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Intravenous Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion), by End-user
  • Hospitals & Clinics Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Cancer Research Institutes Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Ambulatory Surgical Centers Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion), by Application
  • Melanoma Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Breast Cancer Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Lung Cancer Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Ovarian Cancer Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Prostate Cancer Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion), by Virus Type
  • Herpes Simplex Virus (HSV) Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Adenovirus Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Vaccinia Virus Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Newcastle Disease Virus Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Reovirus Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Others Segment Estimates and Forecasts, 2022–2036 (USD Billion)
  • Global Oncolytic Virus Immunotherapy Market Share, by Region
  • North America Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • U.S. Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Canada Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Europe Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • UK Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Germany Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • France Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Italy Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Spain Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Russia Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Asia Pacific Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • China Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • India Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Japan Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Australia Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • South Korea Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Latin America Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Mexico Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Brazil Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Argentina Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Middle East & Africa Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • UAE Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Saudi Arabia Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • South Africa Oncolytic Virus Immunotherapy Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Key Company Categorization
  • Company Market Positioning
  • Key Company Market Share Analysis

Get more details on this report

Request Free Sample Report

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →